Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2020

Nov 21, 2020

30071_dirs_2020-11-20_c951ceeb-15e1-48ba-b05f-d7473a82f61d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-19

Reporting Person: SULPIZIO RICHARD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-19 ResMed Common Stock A 1187 Acquired 12867 Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 0 Indirect

Footnotes

F1: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2021, or the annual shareholders meeting in the year following the grant date.

F2: Bank of America, N.A. is Trustee of the xyz Charitable Remainder Unitrust and Mr. xyz has no control over the disposition of the equities held.

F3: Securities held by Bank of America, N.A., Trustee of the Magali Charitable Remainder Unitrust. Mr. Sulpizio has no control over the timing of any disposition of the shares transferred.